Management of interstitial lung disease (ILD)-associated with systemic sclerosis (SSc) Therapeutic indication: absolute decline in FVC >10% (or >200 mL) and/or in DLCO >15% (or 3 mL/min/mmHg) over the 12 months OR immediately for extensive and symptomatic form Symptomatic treatment : vaccination, optimization of GERD treatment, oxygen, rehabilitation, tobacco stop,nutritional support By Dr. Benjamin Thoreau @ThoreauBenjamin #interstitial #lungdisease #ILD #systemicsclerosis #SSc #pulmonary #indications #management #treatment #algorithm
